Editorial
|
|
|
|
|
Prescrire depends on readers' subsciptions only
|
|
|
|
Marketing Authorisations
|
|
|
|
|
No short-term advantages, too many unknowns in the long term
|
|
|
|
|
|
|
|
|
|
|
|
Immediate or sustained release: too risky for a drug with no proven benefit
|
|
|
|
|
|
|
|
|
|
|
|
No advantage for patients
|
|
|
|
|
|
|
|
|
|
|
|
Naming clinical trials is part of marketing strategies
|
|
|
|
|
|
|
|
|
|
An extra window of time before liver transplantation
|
|
|
|
|
|
|
|
Adverse Effects
|
|
|
|
|
Troubling cases, especially with paroxetine
|
|
|
|
|
|
|
|
|
|
ACE inhibitors should be avoided during pregnancy
|
|
|
|
|
|
|
|
|
|
Caution before prescribing a neuroleptic, also during treatment
|
|
|
|
|
|
|
|
|
|
Troubling results in one trial
|
|
|
|
|
|
|
|
|
|
A serious risk against poorly established efficacy
|
|
|
|
|
|
Reviews
|
|
|
|
|
From the age of 2 months, for all infants
|
|
|
|
|
|
|
|
|
|
Infant immunisation with pneumococcal conjugate vaccine
|
|
|
|
|
|
|
|
|
|
Unexpected results of a clinical trial
|
|
|
|
|
|
Outlook
|
|
|
|
|
Hyped up announcements but still no medicines
|
|
|
|
|
|
|
|
|
|
Much room for improvement
|
|
|
|
Forum
|
|
|
|
|
Long term therapy should be avoided
|
|
|
|
|
|
|
|
|
|
Prescrire' assessment challenged and confirmed
|
|
|
|